Monoclonal Antibodies Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Monoclonal Antibodies Market
Monoclonal Antibodies Market: By Application [Oncology, Autoimmune and inflammatory diseases, Respiratory diseases and Ophthalmology] & By Geography (Europe, Asia Pacific, North America, Rest of the World) - Forecast(2018 - 2023)
Report Code : HCR 0320
Updated Date: 16 May, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Monoclonal Antibodies – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Monoclonal Antibodies – Market Forces
   4.1. Drivers
      4.1.1. Technological enhancements and huge R&D in genomic studies
      4.1.2. Continuous improvement and innovation in Monoclonal Antibodies technologies
      4.1.3. Growing Population
   4.2. Restrains
      4.2.1 High developmental costs
   4.3. Opportunities
      4.3.1 Emerging Economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Monoclonal Antibodies – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Monoclonal Antibodies Market, By Application
   6.1. Oncology
   6.2. Autoimmune and inflammatory diseases
   6.3. Respiratory diseases
   6.4. Ophthalmology UV-Visible (Photodiode Array, Handheld)
   6.5. Others
7. Monoclonal Antibodies Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Monoclonal Antibodies – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. AbGenomics
   9.2. ADC Therapeutics
   9.3. Agensys
   9.4. Alexion Pharmaceuticals
   9.5. ALMAC Group
   9.6. Ambrx
   9.7. Astellas Pharma
   9.8. AstraZeneca
   9.9. Bayer HealthCare
   9.10. Biogen
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix

   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of expert Insights
   10.6. Disclaimer
Antibodies are increasingly becoming the preferred choice to treat several disorders such as respiratory diseases, oncology, and inflammatory diseases. The rising application of these antibodies in drug development increases revenue generation in the mAbs market, contributing to the overall market growth. Globally, technological enhancements and huge R&D in genomic studies, continuous improvement and innovation in Monoclonal Antibodies technologies and growing population are the prime growth drivers of Monoclonal Antibodies market. In addition, Increase in adoption of Monoclonal Antibodies in emerging economies such as China, India and others, will create new opportunities for moloclonal antibodies market. However, higher cost of the research and development, and complex government approval processes are the key restraints for moloclonal antibodies market.

 Monoclonal Antibodies Market

Globally, Asia Pacific will be the fastest-growing region in the mAbs market and is likely to grow. Much of the region’s growth can be attributed to the rising occurrence of diseases and healthcare investments provided by the respective governments and increased out-of-pocket expenditure by individuals. Moreover, the rising number of initiatives undertaken by major vendors to assist patients in the Asia Pacific countries and recent launches of new products are significant contributors to the high sales of sales mAbs in this region.

This report identifies the global Monoclonal Antibodies market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Monoclonal Antibodies market.

This report segments global Monoclonal Antibodies market on the basis of application, and regional market as follows:
  • Global Monoclonal Antibodies Market By Application: Oncology, Autoimmune and inflammatory diseases, Respiratory diseases and Ophthalmology and Others
  • This report has been further segmented into major regions, which include detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region. The major countries considered under the Asia-Pacific region are India, China, South Korea and Japan. The major countries considered under the European region are Germany, U.K., France, Italy, Spain and Russia. The major countries considered under the North American region are United States, Canada and Mexico

This report identifies all the major companies operating in the global Monoclonal Antibodies market. Some of the major companies’ profiles in detail are as follows:
  • AbGenomics
  • ADC Therapeutics
  • Agensys
  • Alexion Pharmaceuticals
  • ALMAC Group
List of Tables:

Table 1: Monoclonal Antibodies Market Overview 2017-2023
Table 2: Monoclonal Antibodies Market Leader Analysis 2017-2018 (US$)
Table 3: Monoclonal Antibodies Market Product Analysis 2017-2018 (US$)
Table 4: Monoclonal Antibodies Market End User Analysis 2017-2018 (US$)
Table 5: Monoclonal Antibodies Market Patent Analysis 2013-2018* (US$)
Table 6: Monoclonal Antibodies Market Financial Analysis 2017-2018 (US$)
Table 7: Monoclonal Antibodies Market Driver Analysis 2017-2018 (US$)
Table 8: Monoclonal Antibodies Market Challenges Analysis 2017-2018 (US$)
Table 9: Monoclonal Antibodies Market Constraint Analysis 2017-2018 (US$)
Table 10: Monoclonal Antibodies Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Monoclonal Antibodies Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Monoclonal Antibodies Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Monoclonal Antibodies Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Monoclonal Antibodies Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Monoclonal Antibodies Market Value Chain Analysis 2017-2018 (US$)
Table 16: Monoclonal Antibodies Market Pricing Analysis 2018-2023 (US$)
Table 17: Monoclonal Antibodies Market Opportunities Analysis 2018-2023 (US$)
Table 18: Monoclonal Antibodies Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Monoclonal Antibodies Market Supplier Analysis 2017-2018 (US$)
Table 20: Monoclonal Antibodies Market Distributor Analysis 2017-2018 (US$)
Table 21: Monoclonal Antibodies Market Trend Analysis 2017-2018 (US$)
Table 22: Monoclonal Antibodies Market Size 2017 (US$)
Table 23: Monoclonal Antibodies Market Forecast Analysis 2018-2023 (US$)
Table 24: Monoclonal Antibodies Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Monoclonal Antibodies Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 26: Monoclonal Antibodies Market By Application, Revenue & Volume, By Oncology, 2018-2023 ($)
Table 27: Monoclonal Antibodies Market By Application, Revenue & Volume, By Autoimmune and inflammatory diseases, 2018-2023 ($)
Table 28: Monoclonal Antibodies Market By Application, Revenue & Volume, By Respiratory diseases, 2018-2023 ($)
Table 29: Monoclonal Antibodies Market By Application, Revenue & Volume, By Ophthalmology UV-Visible (Photodiode Array, Handheld), 2018-2023 ($)
Table 30: North America Monoclonal Antibodies Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 31: South america Monoclonal Antibodies Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 32: Europe Monoclonal Antibodies Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 33: APAC Monoclonal Antibodies Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 34: Middle East & Africa Monoclonal Antibodies Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 35: Russia Monoclonal Antibodies Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 36: Israel Monoclonal Antibodies Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 37: Top Companies 2017 (US$)Monoclonal Antibodies Market, Revenue & Volume
Table 38: Product Launch 2017-2018Monoclonal Antibodies Market, Revenue & Volume
Table 39: Mergers & Acquistions 2017-2018Monoclonal Antibodies Market, Revenue & Volume

List of Figures

Figure 1: Overview of Monoclonal Antibodies Market 2017-2023
Figure 2: Market Share Analysis for Monoclonal Antibodies Market 2017 (US$)
Figure 3: Product Comparison in Monoclonal Antibodies Market 2017-2018 (US$)
Figure 4: End User Profile for Monoclonal Antibodies Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Monoclonal Antibodies Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Monoclonal Antibodies Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Monoclonal Antibodies Market 2017-2018
Figure 8: Ecosystem Analysis in Monoclonal Antibodies Market 2017
Figure 9: Average Selling Price in Monoclonal Antibodies Market 2017-2023
Figure 10: Top Opportunites in Monoclonal Antibodies Market 2017-2018
Figure 11: Market Life Cycle Analysis in Monoclonal Antibodies Market Market Life Cycle Analysis in 3D Printing
Figure 12: Global By ApplicationMonoclonal Antibodies Market Revenue, 2018-2023 ($)
Figure 13: Global Monoclonal Antibodies Market - By Geography
Figure 14: Global Monoclonal Antibodies Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 15: Global Monoclonal Antibodies Market CAGR, By Geography, 2018-2023 (%)
Figure 16: North America Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 17: US Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 18: US GDP and Population, 2017-2018 ($)
Figure 19: US GDP - Composition of 2017, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2017-2018 ($)
Figure 21: Canada Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 22: Canada GDP and Population, 2017-2018 ($)
Figure 23: Canada GDP - Composition of 2017, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 25: Mexico Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 26: Mexico GDP and Population, 2017-2018 ($)
Figure 27: Mexico GDP - Composition of 2017, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 29: South America Monoclonal Antibodies Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 30: Brazil Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 31: Brazil GDP and Population, 2017-2018 ($)
Figure 32: Brazil GDP - Composition of 2017, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 34: Venezuela Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 35: Venezuela GDP and Population, 2017-2018 ($)
Figure 36: Venezuela GDP - Composition of 2017, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 38: Argentina Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 39: Argentina GDP and Population, 2017-2018 ($)
Figure 40: Argentina GDP - Composition of 2017, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 42: Ecuador Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 43: Ecuador GDP and Population, 2017-2018 ($)
Figure 44: Ecuador GDP - Composition of 2017, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 46: Peru Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 47: Peru GDP and Population, 2017-2018 ($)
Figure 48: Peru GDP - Composition of 2017, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 50: Colombia Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 51: Colombia GDP and Population, 2017-2018 ($)
Figure 52: Colombia GDP - Composition of 2017, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 54: Costa Rica Monoclonal Antibodies Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 55: Costa Rica GDP and Population, 2017-2018 ($)
Figure 56: Costa Rica GDP - Composition of 2017, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 58: Europe Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 59: U.K Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 60: U.K GDP and Population, 2017-2018 ($)
Figure 61: U.K GDP - Composition of 2017, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 63: Germany Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 64: Germany GDP and Population, 2017-2018 ($)
Figure 65: Germany GDP - Composition of 2017, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 67: Italy Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 68: Italy GDP and Population, 2017-2018 ($)
Figure 69: Italy GDP - Composition of 2017, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 71: France Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 72: France GDP and Population, 2017-2018 ($)
Figure 73: France GDP - Composition of 2017, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2017-2018 ($)
Figure 75: Netherlands Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 76: Netherlands GDP and Population, 2017-2018 ($)
Figure 77: Netherlands GDP - Composition of 2017, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 79: Belgium Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 80: Belgium GDP and Population, 2017-2018 ($)
Figure 81: Belgium GDP - Composition of 2017, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 83: Spain Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 84: Spain GDP and Population, 2017-2018 ($)
Figure 85: Spain GDP - Composition of 2017, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 87: Denmark Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 88: Denmark GDP and Population, 2017-2018 ($)
Figure 89: Denmark GDP - Composition of 2017, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 91: APAC Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 92: China Monoclonal Antibodies Market Value & Volume, 2018-2023
Figure 93: China GDP and Population, 2017-2018 ($)
Figure 94: China GDP - Composition of 2017, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2017-2018 ($)Monoclonal Antibodies Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 96: Australia Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 97: Australia GDP and Population, 2017-2018 ($)
Figure 98: Australia GDP - Composition of 2017, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 100: South Korea Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 101: South Korea GDP and Population, 2017-2018 ($)
Figure 102: South Korea GDP - Composition of 2017, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 104: India Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 105: India GDP and Population, 2017-2018 ($)
Figure 106: India GDP - Composition of 2017, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2017-2018 ($)
Figure 108: Taiwan Monoclonal Antibodies Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 109: Taiwan GDP and Population, 2017-2018 ($)
Figure 110: Taiwan GDP - Composition of 2017, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 112: Malaysia Monoclonal Antibodies Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 113: Malaysia GDP and Population, 2017-2018 ($)
Figure 114: Malaysia GDP - Composition of 2017, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 116: Hong Kong Monoclonal Antibodies Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 117: Hong Kong GDP and Population, 2017-2018 ($)
Figure 118: Hong Kong GDP - Composition of 2017, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 120: Middle East & Africa Monoclonal Antibodies Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 121: Russia Monoclonal Antibodies Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 122: Russia GDP and Population, 2017-2018 ($)
Figure 123: Russia GDP - Composition of 2017, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 125: Israel Monoclonal Antibodies Market Value & Volume, 2018-2023 ($)
Figure 126: Israel GDP and Population, 2017-2018 ($)
Figure 127: Israel GDP - Composition of 2017, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 129: Entropy Share, By Strategies, 2017-2018* (%)Monoclonal Antibodies Market
Figure 130: Developments, 2017-2018*Monoclonal Antibodies Market
Figure 131: Company 1 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 132: Company 1 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 133: Company 1 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 134: Company 2 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 135: Company 2 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 136: Company 2 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 137: Company 3 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 138: Company 3 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 139: Company 3 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 140: Company 4 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 141: Company 4 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 142: Company 4 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 143: Company 5 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 144: Company 5 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 145: Company 5 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 146: Company 6 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 147: Company 6 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 148: Company 6 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 149: Company 7 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 150: Company 7 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 151: Company 7 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 152: Company 8 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 153: Company 8 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 154: Company 8 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 155: Company 9 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 156: Company 9 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 157: Company 9 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 158: Company 10 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 159: Company 10 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 160: Company 10 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 161: Company 11 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 162: Company 11 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 163: Company 11 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 164: Company 12 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 165: Company 12 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 166: Company 12 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 167: Company 13 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 168: Company 13 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 169: Company 13 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 170: Company 14 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 171: Company 14 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 172: Company 14 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Figure 173: Company 15 Monoclonal Antibodies Market Net Revenue, By Years, 2017-2018* ($)
Figure 174: Company 15 Monoclonal Antibodies Market Net Revenue Share, By Business segments, 2017 (%)
Figure 175: Company 15 Monoclonal Antibodies Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll